AdaptHealth Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AdaptHealth Corp. on August 16, 2021, with the earliest event reported on that same date. The filing details a material definitive agreement and the creation of a direct financial obligation involving the company's wholly owned indirect subsidiary, AdaptHealth LLC.
Key Financial Metrics and Obligations
- Debt Issuance: Completed an offering of $600,000,000 aggregate principal amount of 5.125% Senior Notes due 2030.
- Use of Proceeds: Gross proceeds were utilized to repay Preferred Notes held by affiliates of Assured Investment Management LLC, repay amounts outstanding under the revolving credit facility, pay related fees and expenses, and fund general corporate purposes.
- Existing Debt Structure: The new Notes rank equally with existing $350,000,000 of 6.125% senior notes due 2028 and $500,000,000 of 4.625% senior notes due 2029.
- Covenant Adjustments: The Credit Agreement Amendment increased the amount of unencumbered cash permitted to reduce total indebtedness in financial covenant calculations for the fiscal quarters ending September 30, 2021, and December 31, 2021.
Material Changes
The primary material change is the execution of the Second Amendment to the Credit Agreement dated January 20, 2021, and the subsequent issuance of the 2030 Senior Notes. This transaction altered the company's capital structure by replacing specific affiliate-held promissory notes and reducing revolver balances with long-term senior unsecured debt.
Outlook, Risks, and Terms
- Maturity and Interest: The Notes mature on March 1, 2030, with interest payable semiannually starting March 1, 2022.
- Redemption Terms: The Notes are redeemable after March 1, 2025, at specified premiums declining to 100% by March 2027. Prior to March 2025, redemption is possible at a "make-whole" premium or up to 40% of the principal using equity offering proceeds at 105.125%.
- Guarantees: The Notes are guaranteed by AdaptHealth's subsidiaries that are borrowers or guarantors under the Credit Agreement, as well as its direct parent, AdaptHealth Intermediate Holdco LLC.
- Liquidity and Contingencies: The filing does not provide specific liquidity ratios or cash flow figures for the period. The Notes are unsecured and effectively subordinated to secured debt under the Credit Agreement.
Investor Verification Checklist
- Verify the exact amount of Preferred Notes repaid and the remaining balance on the revolving credit facility post-transaction.
- Review the full text of the Second Amendment to the Credit Agreement (Exhibit 10.1) for specific covenant thresholds.
- Confirm the impact of the new debt issuance on the company's leverage ratios and interest coverage.
- Assess the terms of the "make-whole" premium and the conditions triggering mandatory purchase offers upon asset sales or change of control.